Hydrogenated amorphous silicon colloids of low surface area ( <5m 2 /g) are shown to exhibit complete in-vitro biodegradation into orthosilicic acid within 10-15 days at 37°C. When converted into polycrystalline silicon colloids, by high temperature annealing in an inert atmosphere, microparticle solubility is dramatically reduced. The data suggests that amorphous silicon does not require nanoscale porosification for full in-vivo biodegradability. This has significant implications for using a-Si:H coatings for medical implants in general, and orthopaedic implants in particular. The high sphericity and biodegradability of submicron particles may also confer advantages with regards to contrast agents for medical imaging.
Introduction
The biocompatibility of various nanostructures of the semiconductor silicon is receiving increasing attention for drug delivery, medical imaging and biosensing [1] [2] [3] . The in-vitro biodegradability of nanostructured porous forms of very high surface area was first revealed in the 1990's and its use for medical imaging purposes has been demonstrated in-vivo [4, 5] . Mesoporous silicon is commonly derived by etching single crystal or polycrystalline wafers and powders and largely retains the crystallinity of such feedstocks [6] . Micromachined silicon, macroporous and large grain size polycrystalline silicon microparticles do not exhibit significant biodegradability, in-vitro nor in-vivo [7 , 8] . Chemical Vapor Deposition techniques (CVD) allow the formation of polydisperse silicon micro and nanoparticles, with size ranging from 0.5 to 5 micrometers, and with a highly spherical shape [9] . The combined low surface roughness, spherical topology and high refractive index, results in silicon "colloids" or microsphere assemblies working very well as optical microcavities in the IR region [10] . They can be porous, amorphous or polycrystalline, depending on the decomposition parameters [11] . Silicon colloids can be seen as a new enabling particulate system with many applications in materials science, photonics, cosmetics and sensing [9, 10, 12, 13, 14] . Here we report on the in-vitro biodegradability of nanostructured amorphous and polycrystalline silicon colloids. Our data shows much higher biodegradability of amorphous silicon colloids than that of nanostructured polycrystalline equivalents.
Experimental
Silicon colloids for biodegradability assays were fabricated by the method described elsewhere [9] . Amorphous silicon colloids were obtained by decomposing disilane at 450°C in a CVD reactor. Polycrystalline silicon colloids were achieved by annealing the amorphous colloids at 800°C for 1 hour in an argon inert atmosphere. Structural properties of the colloids were studied by using several techniques, namely Scanning Electron Microscopy (SEM), X Ray Powder Diffraction (XRD) and Raman Spectroscopy (RS). The samples for XRD analysis consist of big clusters, of 100 micrometers in height by 1 cm 2 in area approximately, containing many microspheres, which were deposited on silica substrates. We used an X-ray wavelength, λ = 1.54187 Å, and the spot size was about 4 mm diameter, therefore the obtained X-ray spectra correspond to an average signal produced by millions of microspheres. The samples for (RS) consist of isolated microspheres on silica substrates. Raman spectra were measured on single microspheres by using a Jobin-Ivon T64000 triple monocromator provided with a microprobe accessory and pumped with an Ar ion laser. The excitation wavelength was 545 nm, beam power of 10µW and spot size of 10 µm, corresponding to a very low Micro-Raman excitation density of 10 Wcm -2 There were thus small beam heating effects, as it is well known that temperature rises can significantly affect Raman lineshape and position [6] .
Gas adsorption/desorption analysis was carried out on a Micromeritics Tristar instrument with sample de-gassing at 70°C under vacuum for 1hr and BET analysis of the isotherms. In-vitro biodegradability into orthosilicic acid was quantitatively assessed using a molybdenum blue based assay [15] . Sealed plastic containers of 200ml volume containing 5mg silicon samples in trizma buffer (pH 7.4 at 37C) were agitated at 50rpm in a water bath for periods up to 10 days. Aliquots of 2.5ml were withdrawn for analysis at predetermined time points. These were acidified, reacted with 1% disodium EDTA, then 5% ammonium molybdate and then 17% sodium sulphite solution. Their resulting absorbance at 700nm was then converted to an orthosilicic acid concentration by comparison with standard solutions of known concentration. Figure 1 shows the highly spherical nature of the microparticles. The colloids have a diameter from 0.5 to 5 micrometers, and the mean diameter is 1.8 micrometers. The density of a-Si:H is a strong function of the hydrogen content and other factors. Assuming a value of 1.9g/cm 3 (equivalent to about 20 atomic % H) and perfectly spherical particles (surface area of 4π r 2 ), gives a theoretical value of 1.7m 2 /g for the surface area of a non-porous colloid [16] . BET analysis gave a value of 1.8m 2 /g, which is in good agreement. This demonstrates that the amorphous microparticle colloid possesses minimal microporosity and mesoporosity. Indeed optical scattering from single particles is sensitive to both chemical composition and porosity with hollow particles having completely different scattering spectra to those of the compact particles under study here [9] . The application of the Scherrer equation to the peak centered around 2ϕ=28° gives a crystallite size of about 30 nm [17] . This transformation can also be seen through micro-Raman analysis, as it is illustrated by the spectra (a), (b) and (c) of Figure 3 , that correspond to amorphous, polycrystalline and the reference sample respectively. These spectra have been normalized and they were measured on single microspheres. Figure 4 compares the solubility of hydrogenated amorphous silicon with thermally crystallized material of similar particle size distribution. Whereas the amorphous colloid undergoes >90% dissolution within 10 days, the equivalent polycrystalline colloid (microspheres with 30nm grain size) has lost under 10% of its mass and maintains a stable weight after the first few days.
Results

Discussion & conclusions
We believe this is the first time that the biodegradability of amorphous semiconducting silicon has been quantitatively assessed. Biodegradation of silicon nanostructures has been monitored ex-situ by electron microscopy of the material remaining or by a chemical method measuring the accumulation of biodegradable products (18, 1, 2) . In this study we opted for the latter technique to provide quantification data on degradation kinetics of silicon structures.
Porous silicon in aqueous conditions undergoes hydrolysis to form orthosilicic acid and the reaction is catalyzed by OH-, hence the rate of dissolution increases with increasing pH.
Dissolution of unoxidised silicon can be described with a simplified two step process.
Si + 2H2Oà SiO2 + 2H2 SiO2 + 2H2Oà Si (OH)4
The oxidative first step generates hydrogen gas and is dependent on both electronic band gap and doping of the semiconductor. Complete hydrolysis of the oxide phase then generates orthosilicic acid, which is the natural bioavailable form of silicon, freely diffusible in human tissues, and readily excreted via the kidneys [4, 19] . The biodegradation study is carried out at pH 7.4 and 37°C conditions to mimic in vivo conditions. During a study of the bioactivity of deposited nanocrystalline silicon layers it was noted that layers which were virtually amorphous underwent significant corrosion in simulated human plasma, but the etch rate was not quantified [18] . Here we have directly compared the in-vitro solubility of amorphous and polycrystalline powder of the same particle size distribution.
It is interesting to compare this result with that of silica where the equilibrium solubility of the amorphous phase in water is approximately 10 times higher than that of crystalline quartz [19] . Quartz is very resistant to hydrolysis and does not biodegrade in physiological environments. Certain forms of high surface area, amorphous mesoporous silica however does show biodegradability whilst others show high stability against hydrolysis [20, 21] . It seems likely that amorphous silicon in various structural forms will show much faster biodegradation kinetics to those of both amorphous silica and polycrystalline silicon. This has encouraging implications for the use of amorphous silicon coatings in medical implant applications where a temporary structure conveys advantages in device efficacy and biocompatibility regarding its intended use. The observation of its full biodegradability without porosification will expand the fabrication options in this regard. Mesoporosity is a major attribute for applications such as drug delivery but there are numerous uses in orthopedics and orthopedic tissue engineering where controlled silicic acid release is used to stimulate bone growth [1, 2, 22] . Fully biodegradable spheres of submicron diameter are also of interest as contrast agents for both in-vitro and in-vivo medical imaging [23] . The biocompatibility of hydrogenated amorphous silicon is worthy of detailed assessment.
